- Home
- RWT vs MYGN Comparison
RWT vs MYGN Comparison
Compare RWT & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWT
- MYGN
- Stock Information
- Founded
- RWT 1994
- MYGN 1991
- Country
- RWT United States
- MYGN United States
- Employees
- RWT 283
- MYGN N/A
- Industry
- RWT Real Estate Investment Trusts
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RWT Real Estate
- MYGN Health Care
- Exchange
- RWT Nasdaq
- MYGN Nasdaq
- Market Cap
- RWT 678.2M
- MYGN 744.7M
- IPO Year
- RWT 1995
- MYGN 1995
- Fundamental
- Price
- RWT $5.54
- MYGN $7.64
- Analyst Decision
- RWT Buy
- MYGN Hold
- Analyst Count
- RWT 9
- MYGN 16
- Target Price
- RWT $7.67
- MYGN $20.17
- AVG Volume (30 Days)
- RWT 1.6M
- MYGN 1.0M
- Earning Date
- RWT 04-30-2025
- MYGN 05-06-2025
- Dividend Yield
- RWT 12.92%
- MYGN N/A
- EPS Growth
- RWT N/A
- MYGN N/A
- EPS
- RWT 0.32
- MYGN N/A
- Revenue
- RWT $242,497,000.00
- MYGN $837,600,000.00
- Revenue This Year
- RWT N/A
- MYGN $2.99
- Revenue Next Year
- RWT $11.82
- MYGN $8.36
- P/E Ratio
- RWT $17.31
- MYGN N/A
- Revenue Growth
- RWT 52.90
- MYGN 11.21
- 52 Week Low
- RWT $4.68
- MYGN $7.35
- 52 Week High
- RWT $8.15
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- RWT 44.79
- MYGN 28.54
- Support Level
- RWT $4.68
- MYGN $7.69
- Resistance Level
- RWT $5.43
- MYGN $8.27
- Average True Range (ATR)
- RWT 0.30
- MYGN 0.56
- MACD
- RWT 0.00
- MYGN 0.04
- Stochastic Oscillator
- RWT 60.99
- MYGN 17.37
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.